Literature DB >> 22904337

Urethral exudates of men with Neisseria gonorrhoeae infections select a restricted lipooligosaccharide phenotype during transmission.

Stephanie E McLaughlin1, Hui Cheng, Khalil G Ghanem, Zhijie Yang, Johan Melendez, Jonathan Zenilman, J McLeod Griffiss.   

Abstract

Neisseria gonorrhoeae lipooligosaccharides (LOSs) induce immunoglobulin G that protects men from experimental infection. This raises the possibility that an LOS vaccine might prevent gonorrhea. Gonococci make different LOS molecules, depending on whether 3 genes, lgtA, lgtC, and lgtD, are in frame (IF) or out of frame (OOF). Mispairing of polymeric guanine (polyG) tracts within each gene determines its frame during replication. We amplified lgtA, lgtC, and lgtD from diagnostic slides of urethral exudates and sequenced their polyG tracts. We found that lgtA in exudative bacteria is IF and that lgtC is OOF. The frame of lgtD varied widely: it was OOF in most but not all cases. This genotype would result in synthesis of polylactosamine α chains that could be sialylated. Polylactosamine α chains would enhance virulence, and their sialylation would enable gonococci to survive within polymorphonuclear cells; however, an active LgtD in a few bacteria could provide a survival advantage in other sites of infection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22904337      PMCID: PMC3448965          DOI: 10.1093/infdis/jis481

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  19 in total

1.  Effect of exogenous sialylation of the lipooligosaccharide of Neisseria gonorrhoeae on opsonophagocytosis.

Authors:  J J Kim; D Zhou; R E Mandrell; J M Griffiss
Journal:  Infect Immun       Date:  1992-10       Impact factor: 3.441

2.  Modification by sialic acid of Neisseria gonorrhoeae lipooligosaccharide epitope expression in human urethral exudates: an immunoelectron microscopic analysis.

Authors:  M A Apicella; R E Mandrell; M Shero; M E Wilson; J M Griffiss; G F Brooks; C Lammel; J F Breen; P A Rice
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

3.  Structural determination of oligosaccharides derived from lipooligosaccharide of Neisseria gonorrhoeae F62 by chemical, enzymatic, and two-dimensional NMR methods.

Authors:  R Yamasaki; B E Bacon; W Nasholds; H Schneider; J M Griffiss
Journal:  Biochemistry       Date:  1991-10-29       Impact factor: 3.162

4.  The geography of gonorrhea. Empirical demonstration of core group transmission.

Authors:  R B Rothenberg
Journal:  Am J Epidemiol       Date:  1983-06       Impact factor: 4.897

5.  The lgtABCDE gene cluster, involved in lipooligosaccharide biosynthesis in Neisseria gonorrhoeae, contains multiple promoter sequences.

Authors:  Derek C Braun; Daniel C Stein
Journal:  J Bacteriol       Date:  2004-02       Impact factor: 3.490

6.  Instability of expression of lipooligosaccharides and their epitopes in Neisseria gonorrhoeae.

Authors:  H Schneider; C A Hammack; M A Apicella; J M Griffiss
Journal:  Infect Immun       Date:  1988-04       Impact factor: 3.441

7.  Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men.

Authors:  H Schneider; J M Griffiss; J W Boslego; P J Hitchcock; K M Zahos; M A Apicella
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

8.  Experimental Gonococcal Infection in Male Volunteers: Cumulative Experience with Neisseria gonorrhoeae Strains FA1090 and MS11mkC.

Authors:  Marcia M Hobbs; P Frederick Sparling; Myron S Cohen; William M Shafer; Carolyn D Deal; Ann E Jerse
Journal:  Front Microbiol       Date:  2011-05-31       Impact factor: 5.640

9.  Variation of gonococcal lipooligosaccharide structure is due to alterations in poly-G tracts in lgt genes encoding glycosyl transferases.

Authors:  Q L Yang; E C Gotschlich
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

10.  Genetic locus for the biosynthesis of the variable portion of Neisseria gonorrhoeae lipooligosaccharide.

Authors:  E C Gotschlich
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

View more
  4 in total

1.  Bypassing Phase Variation of Lipooligosaccharide (LOS): Using Heptose 1 Glycan Mutants To Establish Widespread Efficacy of Gonococcal Anti-LOS Monoclonal Antibody 2C7.

Authors:  Srinjoy Chakraborti; Sunita Gulati; Bo Zheng; Frank J Beurskens; Janine Schuurman; Peter A Rice; Sanjay Ram
Journal:  Infect Immun       Date:  2020-01-22       Impact factor: 3.441

2.  Phase-Variable Heptose I Glycan Extensions Modulate Efficacy of 2C7 Vaccine Antibody Directed against Neisseria gonorrhoeae Lipooligosaccharide.

Authors:  Srinjoy Chakraborti; Lisa A Lewis; Andrew D Cox; Frank St Michael; Jianjun Li; Peter A Rice; Sanjay Ram
Journal:  J Immunol       Date:  2016-05-02       Impact factor: 5.422

3.  Opacity proteins of neisseria gonorrhoeae in lipooligosaccharide mutants lost ability to interact with neutrophil-restricted CEACAM3 (CD66d).

Authors:  Song Zhang; Ya-Ting Tu; Hua-Hua Cai; Hong-Hui Ding; Qiao Li; Ying-Xia He; Xin-Xin Liu; Xin Wang; Feng Hu; Tie Chen; Hong-Xiang Chen
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2016-07-05

Review 4.  Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine.

Authors:  Sunita Gulati; Jutamas Shaughnessy; Sanjay Ram; Peter A Rice
Journal:  Front Immunol       Date:  2019-02-27       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.